AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Apr 3, 2015
29828_dirs_2015-04-03_8780a97f-c545-42e5-a2e3-e84fd2c37366.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-04-01
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-01 | Common Stock | M | 5000 | $19.085 | Acquired | 152422 | Direct |
| 2015-04-01 | Common Stock | S | 3600 | $96.3007 | Disposed | 148822 | Direct |
| 2015-04-01 | Common Stock | S | 1400 | $97.0615 | Disposed | 147422 | Direct |
| 2015-04-01 | Common Stock | S | 1325 | $96.2882 | Disposed | 146097 | Direct |
| 2015-04-01 | Common Stock | S | 675 | $97.133 | Disposed | 145422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-01 | Non-Qualified Stock Option (right to buy) | $19.085 | M | 5000 | Disposed | 2021-01-20 | Common Stock (5000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $95.7981 to $96.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $96.8008 to $97.71. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $95.73 to $96.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $96.78 to $97.60. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.